QA: Provectus Biopharmaceuticals INC in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000315545_2022_Provectus_Biopharmaceuticals_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0000315545, Provectus Biopharmaceuticals INC

  xvar xval
0 AssetsCurrent 3,441,957
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 31,836
3 remainder_Assets 39,563
4 LiabilitiesCurrent 7,700,636
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,205,419
9 ResearchAndDevelopmentExpense 2,766,611
10 remainder_Expenses 114,875
11 remainder_Revenues 0
12 remainder_NetIncome -1,934,283
13 remainder_ComprehensiveNetIncome -370
  yvar yval
0 Assets 3,513,356
1 Liabilities 7,700,636
2 Expenses 5,086,905
3 Revenues 0
4 StockholdersEquity -4,187,280
5 NetIncome -7,021,188
6 ComprehensiveNetIncome -7,021,373
7 BaseVar 9,117,775
8 EconomicCapitalRatiobeforeLimitedLiability -2.88
9 EconomicCapitalRatio 0.726

Edgar->Model Mapping

Feature Distribution

Change over Time